For the past two years, Amerandus Research, with the assistance of fraud investigators at INA, have been collecting information about the cases of, and in several instances contacting, biomedical researchers who believe that allegations and evidence of falsification, fabrication, or plagiarism (including intellectual property theft) they have made were not adequately investigated by their responsible […]
Author Archive: Blogmaster1
Introduction to Fragile X mouse models
As noted in our very first post about clinical trials for Fragile X Syndrome: “The intention here is to take a slightly different perspective. First, it is interesting to note that in many articles describing the results of clinical trials, the repeated positive results of drug tests in “Fragile X” (FX) animal models are cited […]
An update on Fragile X Syndrome treatment research from the Stanford IDD-C Conference
The following video is shared from the FRAXA Research Foundation, whose research director, Dr. Michael Tranfaglia, M.D., gave a talk at the April 21, 2015 Stanford University Intellectual and Developmental Disability Center (IDD-C) research symposium. Dr. Tranfaglia provided both a review of the bases for recent clinical trials as well as various avenues for future […]